Paul Brannelly was hired by Karyopharm Therapeutics Inc., a Natick nuclear transport modulator company, as senior vice president of finance and administration. Prior to joining Karyopharm, Brannelly was vice president of finance at Verastem Inc.
Paul Brannelly was hired by Karyopharm Therapeutics Inc., a Natick nuclear transport modulator company, as senior vice president of finance and administration. Prior to joining Karyopharm, Brannelly was vice president of finance at Verastem Inc.